SEQENS

[Innovation] 👨🔬 🏆 This year, the The Nobel Prize of Chemistry has awarded major discoveries regarding protein engineering:   ➡️ David Baker for computational protein design: based on in silico design followed by in vitro expression to confirm the model, he successfully created a protein exhibiting a folding which wasn’t previously observed in nature and used this ability to engineer proteins for various functions of interest. For example, his team designed specific proteins able to bind to the spike protein of SARS-CoV-2, leaving the virus unable to infect cells.   ➡️ Demis Hassabis and John Jumper from Google DeepMind for protein 3D structure prediction using Artificial Intelligence. This enables scientists to use this model for proteins only known by their sequence of amino acids.   Following the Nobel prize awarded to Frances Arnold in 2018 for the directed evolution of enzymes, this is another recognition for the field of protein engineering, this time for in silico methods.   At SEQENS, we empower innovation to bring the best solutions to our customers, with a constant concern for sustainability.   🔬 Through our site of Nîmes (France) and Protéus by Seqens, SEQENS has internal capabilities for protein engineering in order to optimize enzymes functions. Protein engineering can be used to improve chemical processes using biocatalysis, as well as integrated within synthetic biology for improved or novel metabolic pathways. For example, these capabilities are mobilized to improve the synthesis of Active Pharmaceutical Ingredients 💊, with more efficient and greener processes. 🌿   🔎 Learn more about the Nobel prize : The Nobel Prize in Chemistry 2024 - Popular information - NobelPrize.org 👉 Discover SEQENS expertise in biocatalysis : https://lnkd.in/eU7Yp8nj #Chemistry #NobelPrize #Proteinengineering #Pharmaceuticals #proteusbyseqens #ourscienceforyourfuture #biocatalysis

[CPHI] It's Day 2 at CPHI in Milano! 💊🤝 The booth is filled with meetings and insightful discussions with our customers and partners from all over the pharma industry. Come and meet us on booth 𝟮𝗕𝟱𝟬 to discover : - CRDO & CDMO services - Generic and proprietary APIs - Consumer Health Care - Pharma solvents & excipients #ourscienceforyourfuture #cphi #cphi2024

[CPHI 2024] Let's go for CPHI 2024 in Milano! 🚀 This year marks the 35th anniversary of the major event gathering the entire pharma industry. SEQENS team is ready to welcome you on our booth #2B50 to discuss projects and opportunities for the future. Come and meet us 🤝 #Seqens #CPHIMilano #CPHI2024 #Ourscienceforyourfuture

𝗛𝗶𝗴𝗵𝗹𝘆 𝗣𝗼𝘁𝗲𝗻𝘁 𝗔𝗣𝗜 𝗨𝗻𝗶𝘁 𝗮𝘁 𝗦𝗘𝗤𝗘𝗡𝗦! We are delighted to announce the commissioning and start-up of a new production unit for Highly Potent API (HPAPI) at our Aramon site! 💊 This new unit, representing an investment of almost 30 million euros supported by the #France2030 program, is synonymous with versatility and innovation. It will enable sustainable and competitive production of many molecules, by implementing multiple chemical reactions. This expansion completes our 𝗚𝗠𝗣 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗼𝗳𝗳𝗲𝗿𝗶𝗻𝗴 (intermediates, APIs, encapsulation polymers) by combining these technologies with the handling of highly active molecules. With a production capacity of 10 tons of HPAPI per year, SEQENS is clearly committed to the reindustrialization of France by developing and securing our site in Aramon 🔵⚪🔴 We are proud to contribute to 𝘁𝗵𝗲 𝗳𝘂𝘁𝘂𝗿𝗲 𝗼𝗳 𝘁𝗵𝗲 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 in France and to strengthen our position as a leader in the production of highly active ingredients. Thank you to all the teams involved for their hard work and dedication! 👏 https://lnkd.in/divMt5hp #SEQENS #HPAPI #Pharma #Reindustrialization #Innovation #Ourscienceforyourfuture

[SEQENS Seminar] 𝗟𝗼𝗶 𝘀𝘂𝗿 𝗹𝗲𝘀 𝗺𝗲́𝗱𝗶𝗰𝗮𝗺𝗲𝗻𝘁𝘀 𝗰𝗿𝗶𝘁𝗶𝗾𝘂𝗲𝘀 : 𝗾𝘂𝗲𝗹𝗹𝗲𝘀 𝗺𝗲𝘀𝘂𝗿𝗲𝘀 𝗮𝘂 𝗻𝗶𝘃𝗲𝗮𝘂 𝗱𝗲 𝗹'𝗨𝗘 𝗽𝗼𝘂𝗿 𝘀𝗲́𝗰𝘂𝗿𝗶𝘀𝗲𝗿 𝗹𝗲𝘀 𝗰𝗵𝗮𝗶̂𝗻𝗲𝘀 𝗱𝗲 𝘃𝗮𝗹𝗲𝘂𝗿 𝗱𝗲𝘀 𝗺𝗼𝗹𝗲́𝗰𝘂𝗹𝗲𝘀 𝗰𝗿𝗶𝘁𝗶𝗾𝘂𝗲𝘀 ? A l'occasion de l'édition 2024 du séminaire du groupe SEQENS, le journaliste et éditorialiste Ulysse Gosset a animé un panel d'experts composé de : ✔️ Agnès Buzyn, Ancienne Ministre de la Santé ✔️ Olivier Girard, Direction Générale HERA, European Union ✔️ Thierry Hulot, Président du LEEM ✔️ Céline rubio Déléguée Générale du SICOS (chimie fine & biotech) ✔️ Gildas Barreyre, Secrétaire Général, SEQENS Un échange passionnant pour explorer cette question et proposer des réponses concrètes afin de renforcer notre souveraineté sanitaire et de limiter les pénuries au bénéfice des patients européens. Le Critical Medicines Act devra être un catalyseur clé pour renforcer et promouvoir une production durable de médicaments en Europe. Et, l'ensemble des acteurs de la chaine de valeur du médicaments travaillent ensemble aux mesures à mettre en place au sein de la Critical Medicines Alliance lancée à l'initiative de la European Commission 🤝 Cette question vous intéresse ? Restez connectés et découvrez prochainement cet échange en intégralité sur 𝑆𝑒́𝑞𝑢𝑒𝑛𝑐𝑒, la chaîne de Podcasts du groupe!

[CPHI] In just 2 weeks, CPHI will open its doors in beautiful Milan! We're delighted to announce that SEQENS will be one of +400 exhibitors at Europe's biggest pharma event. Our team is looking forward to meeting you at CPHI to discover our global offer, latest innovations and CSR commitments 🌍🌿! 💊 Don't miss the opportunity to discover our offer of custom APIs and intermediates, proprietary and custom generics, and pharma grade solvents. 📍 Meet us : 𝗕𝗼𝗼𝘁𝗵 𝟮𝗕𝟱𝟬 - October 8th-10th #CPHI2024 #CPHI #Seqens #OurScienceForYourFuture #Pharma #API #Generics  

Merci Dominique Carlac'h de nous avoir fait l'honneur de votre présence, et d'être chaque année au rendez-vous de notre séminaire annuel.

[SEQENS Seminar] 𝗖𝗼𝗺𝗺𝗲𝗻𝘁 𝗿𝗲́𝗱𝘂𝗶𝗿𝗲 𝗹'𝗲𝗺𝗽𝗿𝗲𝗶𝗻𝘁𝗲 𝗲𝗻𝘃𝗶𝗿𝗼𝗻𝗻𝗲𝗺𝗲𝗻𝘁𝗮𝗹𝗲 𝗲𝘁 𝗽𝗿𝗼𝗺𝗼𝘂𝘃𝗼𝗶𝗿 𝘂𝗻𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻 𝗱𝗲 𝗺𝗲́𝗱𝗶𝗰𝗮𝗺𝗲𝗻𝘁𝘀 𝗱𝘂𝗿𝗮𝗯𝗹𝗲𝘀 ? A l'occasion de l'édition 2024 du séminaire du groupe SEQENS, le journaliste et éditorialiste Ulysse Gosset a animé un panel d'experts composé de : ✔️ Gaëlle Macke, Directrice déléguée de la rédaction de Challenges  ✔️ Théo Guillaumot, Directeur des projets santé au sein de la Direction Générale des Entreprises ✔️ Sandrine BOUTTIER STREF, Directrice RSE de Sanofi  ✔️ Sebastien Taillemite, fondateur et PDG d'Ecovamed Pour relever ce défi de taille, seule une réponse collective et concertée permettra une mise en action rapide et efficace. C'est donc ensemble, qu'ils ont soulevé les problématiques à résoudre et les solutions pour y parvenir. Cette question vous intéresse ? Restez connectés et découvrez prochainement cet échange en intégralité sur 𝑆𝑒́𝑞𝑢𝑒𝑛𝑐𝑒, la chaîne de Podcasts du groupe! #Ourscienceforyourfuture #RSE #Durabilité #Sustainablemedicines

[SEQENS Seminar] A look back at our 𝐚𝐧𝐧𝐮𝐚𝐥 𝐬𝐞𝐦𝐢𝐧𝐚𝐫 𝐚𝐭 SEQENS! As we do every year, we enjoyed an afternoon 𝐫𝐢𝐜𝐡 𝐢𝐧 𝐥𝐞𝐜𝐭𝐮𝐫𝐞𝐬 𝐚𝐧𝐝 𝐫𝐨𝐮𝐧𝐝-𝐭𝐚𝐛𝐥𝐞 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐢𝐨𝐧𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐦𝐚𝐣𝐨𝐫 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐢𝐬𝐬𝐮𝐞𝐬 𝐟𝐚𝐜𝐢𝐧𝐠 𝐨𝐮𝐫 𝐠𝐫𝐨𝐮𝐩. We were honored to welcome some 𝐟𝐚𝐬𝐜𝐢𝐧𝐚𝐭𝐢𝐧𝐠 𝐬𝐩𝐞𝐚𝐤𝐞𝐫𝐬 𝐟𝐨𝐫 𝐢𝐧𝐬𝐩𝐢𝐫𝐢𝐧𝐠 𝐬𝐩𝐞𝐞𝐜𝐡𝐞𝐬, including: Cedric Ringenbach, Founder of La Fresque du Climat, Marco Mensink, Managing Director, CEFIC, Dominique Carlac'h, Member of the MEDEF National Executive Council, and 𝐉𝐞𝐚𝐧-𝐏𝐢𝐞𝐫𝐫𝐞 𝐑𝐚𝐟𝐟𝐚𝐫𝐢𝐧, Former Prime Minister, 𝐡𝐨𝐧𝐨𝐫𝐞𝐝 𝐮𝐬 𝐰𝐢𝐭𝐡 𝐭𝐡𝐞𝐢𝐫 𝐩𝐫𝐞𝐬𝐞𝐧𝐜𝐞. The round-tables brought together 𝐦𝐮𝐥𝐭𝐢-𝐝𝐢𝐬𝐜𝐢𝐩𝐥𝐢𝐧𝐚𝐫𝐲 𝐞𝐱𝐩𝐞𝐫𝐭𝐬 𝐨𝐧 𝐦𝐚𝐣𝐨𝐫 𝐭𝐡𝐞𝐦𝐞𝐬 such as: ✔️𝐡𝐞𝐚𝐥𝐭𝐡 𝐬𝐨𝐯𝐞𝐫𝐞𝐢𝐠𝐧𝐭𝐲, ✔️𝐭𝐡𝐞 𝐞𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐚𝐥 𝐟𝐨𝐨𝐭𝐩𝐫𝐢𝐧𝐭 𝐨𝐟 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬, ✔️ 𝐜𝐞𝐥𝐥&𝐠𝐞𝐧𝐞 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬, ✔️ 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐛𝐚𝐭𝐭𝐞𝐫𝐢𝐞𝐬. These round-tables will be presented in detail throughout the week on the SEQENS Group's LinkedIn page, and will shortly give rise to 𝐚 𝐧𝐞𝐰 𝐬𝐞𝐫𝐢𝐞𝐬 𝐨𝐟 𝐩𝐨𝐝𝐜𝐚𝐬𝐭𝐬 𝐨𝐧 𝐨𝐮𝐫 𝐜𝐡𝐚𝐧𝐧𝐞𝐥 "𝑆𝑒́𝑞𝑢𝑒𝑛𝑐𝑒". 𝐌𝐚𝐧𝐲 𝐭𝐡𝐚𝐧𝐤𝐬 𝐭𝐨 𝐚𝐥𝐥 𝐩𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭𝐬 for their commitment and valuable contributions, and to Challenges, 𝐭𝐡𝐞 𝐞𝐯𝐞𝐧𝐭'𝐬 𝐦𝐞𝐝𝐢𝐚 𝐩𝐚𝐫𝐭𝐧𝐞𝐫. 🤝 Together, we continue to shape the future of SEQENS! #ourscienceforyourfuture #Seqens #seminar #Innovation #Leadership #roundtable #Engagement #Future #Podcast

[Live!] A l'occasion de son séminaire annuel, le groupe SEQENS donne la parole à des experts du monde de la santé. Au programme ce matin, une table ronde pour répondre à la problématique : 𝗟𝗲𝘀 𝗕𝗶𝗴 𝗗𝗮𝘁𝗮 𝗮𝘂 𝘀𝗲𝗿𝘃𝗶𝗰𝗲 𝗱𝗲 𝗹𝗮 𝗺𝗲́𝗱𝗲𝗰𝗶𝗻𝗲 : 𝗰𝗼𝗺𝗺𝗲𝗻𝘁 𝗹'𝗜𝗔 𝗽𝗿𝗼𝗳𝗶𝘁𝗲-𝘁-𝗲𝗹𝗹𝗲 𝗮𝘂𝘅 𝘀𝗼𝗶𝗻𝘀 𝗱𝗲 𝘀𝗮𝗻𝘁𝗲́ ?   Un grand merci au Professeur Antoine Tesniere qui a accepté de modérer cet échange. Autour de la table ce matin, nous avons l'honneur d'accueillir : ✔️ Le Professeur Guillaume Assié, Responsable de la Chaire IA Santé à l'Université Paris Cité ✔️ Lucia Cinque, fondatrice de WhiteLab Genomics ✔️ Frédéric Parmentier, Vice-Président Data Science de Ariana Pharma   Restez connectés, les échanges seront bientôt disponibles sous forme d'un podcast sur "𝑆𝑒́𝑞𝑢𝑒𝑛𝑐𝑒", la chaîne du groupe SEQENS 🎙️   #IA #IAsanté #Seqens #Ourscienceforyourfuture